Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Solu-Medrone 2g inj vials
0603020K0BCAEAE
|
Solu-Medrone | Methylprednisolone sodium succinate | Endocrine System | No data available |
|
Somapacitan 10mg/1.5ml inj pf dispos dev
0605010AHAAAAAA
|
Somapacitan | Somapacitan | Endocrine System | No data available |
|
Somapacitan 15mg/1.5ml inj pf dispos dev
0605010AHAAABAB
|
Somapacitan | Somapacitan | Endocrine System | No data available |
|
Somatorelin 50microgram inj ampoules
0605010ACAAAAAA
|
Somatorelin | Somatorelin | Endocrine System | No data available |
|
Somatrogon 24mg/1.2ml inj pre-filled disposable devices
0605010AGAAAAAA
|
Somatrogon | Somatrogon | Endocrine System | No data available |
|
Somatropin (rbe) 1.3mg inj vials
0605010S0AAAAAA
|
Somatropin | Somatropin | Endocrine System | No data available |
|
Somatropin (rbe) 24mg inj cartridges
0605010S0AAASAS
|
Somatropin | Somatropin | Endocrine System | No data available |
|
Somatropin (rbe) 5.3mg inj vials
0605010S0AAAPAP
|
Somatropin | Somatropin | Endocrine System | No data available |
|
Somatropin (rbe) 5mg inj vials
0605010S0AABJBJ
|
Somatropin | Somatropin | Endocrine System | No data available |
|
Somatropin (rmc) 1.33mg inj vials
0605010S0AAACAC
|
Somatropin | Somatropin | Endocrine System | No data available |
|
Somatropin (rmc) 3.33mg inj vials
0605010S0AAAMAM
|
Somatropin | Somatropin | Endocrine System | No data available |
|
Somavert 10mg inj vials
0605010Z0BBAAAA
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 15mg inj vials
0605010Z0BBABAB
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 20mg inj vials
0605010Z0BBACAC
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 25mg inj vials
0605010Z0BBADAD
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Somavert 30mg inj vials
0605010Z0BBAEAE
|
Somavert | Pegvisomant | Endocrine System | No data available |
|
Sondelbay 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BFAAAC
|
Sondelbay | Teriparatide | Endocrine System | No data available |
|
Stanozolol 2mg tablets
0604030T0AAACAC
|
Stanozolol | Stanozolol | Endocrine System | No data available |
|
Stanozolol 5mg tablets
0604030T0AAABAB
|
Stanozolol | Stanozolol | Endocrine System | No data available |
|
Starlix 120mg tablets
0601023U0BBABAB
|
Starlix | Nateglinide | Endocrine System | No data available |
|
Starlix 180mg tablets
0601023U0BBACAC
|
Starlix | Nateglinide | Endocrine System | No data available |
|
Striant SR 30mg muco-adhesive buccal tablets
0604020K0BJAABI
|
Striant | Testosterone | Endocrine System | No data available |
|
Stromba 5mg tablets
0604030T0BBAAAB
|
Stromba | Stanozolol | Endocrine System | No data available |
|
SuperCheck 2 testing strips
0601060D0CZAAA0
|
SuperCheck 2 (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
|
SuperCheck Plus testing strips
0601060D0DSAAA0
|
SuperCheck Plus (Reagent) | Glucose blood testing reagents | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.